Evidence map›Paper›PMID 18537558›Full record

ReviewCombinatorial chemistry & high throughput screening2008

State-selective binding peptides for heterotrimeric G-protein subunits: novel tools for investigating G-protein signaling dynamics.

Christopher A Johnston, Francis S Willard, J Kevin Ramer, Rainer Blaesius, C Natalia Roques, David P Siderovski

Open access · greenAbstract readReview
In one paragraph

Review in Combinatorial chemistry & high throughput screening, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Innovative Approach Reveals How Receptors Control G Protein State Equilibria.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Christopher A JohnstonDepartment of Pharmacology, Lineberger Comprehensive Cancer Center, and UNC Neuroscience Center, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.
Francis S Willard
J Kevin Ramer
Rainer Blaesius
C Natalia Roques
David P Siderovski
Biogen (Switzerland) · CHEli Lilly (Singapore) · SGUniversity of North Carolina at Chapel Hill · US

Funding

Mechanistic studies of a novel G-alpha nucleotide cycleR01GM074268 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SIDEROVSKI, DAVID P. · 2006 to 2009
$902k
Peptide Biosensors For Spatiotemporal G-Protein DynamicsF32GM076944 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOHNSTON, CHRISTOPHER A · 2006 to 2007
$95k
NIGMS NIH HHS F32 GM076944NIGMS NIH HHS R01 GM074268
6 · The paper itself

Abstract

Heterotrimeric G-proteins, comprising Galpha, Gbeta, and Ggamma subunits, are molecular switches that regulate numerous signaling pathways involved in cellular physiology. This characteristic is achieved by the adoption of two principal states: an inactive state in which GDP-bound Galpha is complexed with the Gbetagamma dimer, and an active state in which GTP-bound Galpha is freed of its Gbetagamma binding partner. Structural studies have illustrated the basis for the distinct conformations of these states which are regulated by alterations in three precise 'switch regions' of the Galpha subunit. Discrete differences in conformation between GDP- and GTP-bound Galpha underlie its nucleotide-dependent protein-protein interactions (e.g., with Gbetagamma/receptor and effectors, respectively) that are critical for maintaining their proper nucleotide cycling and signaling properties. Recently, several screening approaches have been used to identify peptide sequences capable of interacting with Galpha (and free Gbetagamma) in nucleotide-dependent fashions. These peptides have demonstrated applications in direct modulation of the nucleotide cycle, assessing the structural basis for aspects of Galpha and Gbetagamma signaling, and serving as biosensor tools in assays for Galpha activation including high throughput drug screening. In this review, we highlight some of the methods used for such discoveries and discuss the insights that can be gleaned from application of these identified peptides.

Indexed as

Signal TransductionAmino Acid SequenceDrug Evaluation, PreclinicalHeterotrimeric GTP-Binding ProteinsMolecular Sequence DataPeptidesSensitivity and SpecificityHeterotrimeric GTP-Binding ProteinsPeptides

Identifiers

PMID18537558
PMCPMC2440659
OpenAlexW2122289899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.